Drawing for MILS

USPTO serial 87461054

MILS

Reviewed by CopyMark Law Group

Reg. 6086041Status 700Renewal
Filing date
Status date
Registration date
Jun 23, 2020
Examiner
COLLIER, DAVID E
Law office
PUBLICATION AND ISSUE SECTION

What this means

This registration is in, or will soon enter, a USPTO maintenance window. Missing a Section 8 or Section 9 filing can cancel the registration.

Status 700: Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six.

Need help with MILS?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Get help with this Renewal, set up monitoring, or talk with CopyMark.
Get Attorney Assistance for just $299*

Plus Government fees of $425

Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Caitlin R. Byczko

Caitlin R. Byczko BARNES & THORNBURG LLP11 SOUTH MERIDIAN STREETINDIANAPOLIS, IN 46204-3535UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
005pharmaceutical preparations and substances to provide immune activity to fight an existing disease; pharmaceutical preparations and substances, namely, preparations that involve removal, manipulation, activation, expansion and reintroduction of t-cellsACTIVEDec 9, 2019

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Jun 23, 2025REM1COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Jun 23, 2020R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
May 20, 2020SUNANOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
May 19, 2020CNPRALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
May 7, 2020SUPCSTATEMENT OF USE PROCESSING COMPLETE
May 7, 2020AITUCASE ASSIGNED TO INTENT TO USE PARALEGAL
Apr 23, 2020IUAFUSE AMENDMENT FILED
Apr 23, 2020EISUTEAS STATEMENT OF USE RECEIVEDThe applicant filed a Statement of Use with specimens showing the mark in actual commerce. The USPTO will review the filing for compliance. If accepted, the mark can proceed to registration; if deficient, the USPTO may issue a requirement or office action.
Nov 29, 2019EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Nov 27, 2019EX2GSOU EXTENSION 2 GRANTED
Nov 27, 2019EXT2SOU EXTENSION 2 FILED
Nov 27, 2019EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Jun 6, 2019EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Jun 4, 2019EX1GSOU EXTENSION 1 GRANTED
Jun 4, 2019EXT1SOU EXTENSION 1 FILED
Jun 4, 2019EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Dec 4, 2018NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Oct 9, 2018NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Oct 9, 2018PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Sep 19, 2018NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Aug 27, 2018CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER
Feb 27, 2018GNS3NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Feb 27, 2018GNSLLETTER OF SUSPENSION E-MAILED
Feb 27, 2018CNSLSUSPENSION LETTER WRITTEN
Feb 26, 2018TEMETEAS/EMAIL CORRESPONDENCE ENTERED
Feb 26, 2018CRFACORRESPONDENCE RECEIVED IN LAW OFFICE
Feb 26, 2018TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Aug 24, 2017GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Aug 24, 2017GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Aug 24, 2017CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Aug 22, 2017DOCKASSIGNED TO EXAMINER
May 31, 2017NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED
May 26, 2017NWAPNEW APPLICATION ENTERED

Frequently asked questions

Related guidance